At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

The study is the first set of global estimates directly linking diabetes prevalence with treatment coverage over a ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

New guidelines for diabetes treatment, mpox research, and healthcare system improvements discussed in comprehensive health ...

KARACHI: Diabetes has led to a surge in severe health complications in Pakistan with nearly three million patients suffering ...

Gros, discussed the latest updates regarding their tegoprubart treatment. In an interview with The News-Letter, Gros provided ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...